Virtual Medicinal Product (VMP) - Generic Pylera 140mg/125mg/125mg capsules
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Generic Pylera 140mg/125mg/125mg capsules | Start Date 28-06-2024 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- capsule
- Unit Dose UOM
- capsule
Summary
- Prescribing Status
- Never Valid To Prescribe As A VMP
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral capsule
- Ontology Form/Route
- capsule.oral
- Name Basis
- Other
Codes
- ATC Code
- A02BD08
- BNF Codes
-
- BNF code 01030500
| Code | Start Date | End Date |
|---|---|---|
| 43008311000001105 | 28-06-2024 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Bismuth subcitrate potassium | Based on Ingredient Substance | 140 mg | ||
| Metronidazole | Based on Ingredient Substance | 125 mg | ||
| Tetracycline hydrochloride | Based on Ingredient Substance | 125 mg |
Name
Metronidazole
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
125
Strength and UOM (Dmr)
Name
Tetracycline hydrochloride
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
125
Strength and UOM (Dmr)
Name
Bismuth subcitrate potassium
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
140
Strength and UOM (Dmr)
Parent Products
-
VTMNo Parent VTM
-
VMP(Current) Generic Pylera 140mg/125mg/125mg cap...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 120 capsule |